Strategies for ocular siRNA delivery: Potential and limitations of non-viral nanocarriers

Controlling gene expression via small interfering RNA (siRNA) has opened the doors to a plethora of therapeutic possibilities, with many currently in the pipelines of drug development for various ocular diseases. Despite the potential of siRNA technologies, barriers to intracellular delivery signifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakur, Ajit, Fitzpatrick, Scott, Zaman, Abeyat, Kugathasan, Kapilan, Muirhead, Ben, Hortelano, Gonzalo, Sheardown, Heather
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533807/
https://www.ncbi.nlm.nih.gov/pubmed/22686441
http://dx.doi.org/10.1186/1754-1611-6-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533807/
https://www.ncbi.nlm.nih.gov/pubmed/22686441
http://dx.doi.org/10.1186/1754-1611-6-7

Ejemplares similares